v3.26.3
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Product revenue, net $ 107,225 $ 74,380 $ 282,452 $ 206,038
Costs and expenses:        
Cost of goods sold 12,429 10,996 35,515 31,622
Research and development 11,058 7,483 30,510 23,291
Selling, general and administrative 64,108 46,459 178,287 134,870
Amortization of intangible assets 2,711 2,711 8,132 8,132
Total costs and expenses 90,306 67,649 252,444 197,915
Income from operations 16,919 6,731 30,008 8,123
Other income (expense):        
Interest and other income 827 1,158 3,484 3,281
Loss on debt extinguishment, net 0 0 (30,782) 0
Interest expense (6,456) (7,268) (20,287) (21,931)
Total other expense (5,629) (6,110) (47,585) (18,650)
Net income (loss) before income taxes 11,290 621 (17,577) (10,527)
Income tax benefit (expense) 0 0 0 0
Net income (loss) 11,290 621 (17,577) (10,527)
Other comprehensive income (loss), net of tax:        
Foreign currency translation adjustments (1) (1) 14 0
Comprehensive income (loss) $ 11,289 $ 620 $ (17,563) $ (10,527)
Net loss per common share - basic (in dollars per share) $ 0.06 $ 0.00 $ (0.10) $ (0.07)
Net loss per common share - Diluted (in dollars per share) $ 0.06 $ 0.00 $ (0.10) $ (0.07)
Weighted average common shares outstanding - basic (in shares) 180,941,748 163,649,932 174,800,967 158,559,467
Weighted average common shares outstanding - Diluted (in shares) 189,924,032 177,617,307 174,800,967 158,559,467
Product revenue, net        
Product revenue, net $ 106,267 $ 74,063 $ 279,725 $ 199,573
Royalty, contract and other revenue        
Product revenue, net $ 958 $ 317 $ 2,727 $ 6,465